The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.
Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020
Open accessAbstract
This report compiles and summarizes all recommendations from CDC's Advisory Committee on Immunization Practices (ACIP) for use of meningococcal vaccines in the United States. As a comprehensive summary and update of previously published recommendations, it replaces all previously published reports and policy notes. This report also contains new recommendations for administration of booster doses of serogroup B meningococcal (MenB) vaccine for persons at increased risk for serogroup B meningococcal disease. These guidelines will be updated as needed on the basis of availability of new data or licensure of new meningococcal vaccines. ACIP recommends routine vaccination with a quadrivalent meningococcal conjugate vaccine (MenACWY) for adolescents aged 11 or 12 years, with a booster dose at age 16 years. ACIP also recommends routine vaccination with MenACWY for persons aged ≥2 months at increased risk for meningococcal disease caused by serogroups A, C, W, or Y, including persons who have persistent complement component deficiencies; persons receiving a complement inhibitor (e.g., eculizumab [Soliris] or ravulizumab [Ultomiris]); persons who have anatomic or functional asplenia; persons with human immunodeficiency virus infection; microbiologists routinely exposed to isolates of Neisseria meningitidis; persons identified to be at increased risk because of a meningococcal disease outbreak caused by serogroups A, C, W, or Y; persons who travel to or live in areas in which meningococcal disease is hyperendemic or epidemic; unvaccinated or incompletely vaccinated first-year college students living in residence halls; and military recruits. ACIP recommends MenACWY booster doses for previously vaccinated persons who become or remain at increased risk.In addition, ACIP recommends routine use of MenB vaccine series among persons aged ≥10 years who are at increased risk for serogroup B meningococcal disease, including persons who have persistent complement component deficiencies; persons receiving a complement inhibitor; persons who have anatomic or functional asplenia; microbiologists who are routinely exposed to isolates of N. meningitidis; and persons identified to be at increased risk because of a meningococcal disease outbreak caused by serogroup B. ACIP recommends MenB booster doses for previously vaccinated persons who become or remain at increased risk. In addition, ACIP recommends a MenB series for adolescents and young adults aged 16-23 years on the basis of shared clinical decision-making to provide short-term protection against disease caused by most strains of serogroup B N. meningitidis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2013) · Pediatrics · doi:10.1542/peds.2013-2511 · Cited by 1,845
HUMAN IMMUNITY TO THE MENINGOCOCCUS
Goldschneider, I., Gotschlich, E. C., & Artenstein, M. S. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.129.6.1307 · Cited by 1,294
Karch, D. L., Dahlberg, L. L., & Patel, N. (2010) · PsycEXTRA Dataset · doi:10.1037/e587232010-001 · Cited by 745
Infectious diseases associated with complement deficiencies
Figueroa, J. E., & Densen, P. (1991) · Clinical Microbiology Reviews · doi:10.1128/cmr.4.3.359 · Cited by 729
Meningococcal carriage by age: a systematic review and meta-analysis
Christensen, H., May, M., Bowen, L., Hickman, M., & Trotter, C. L. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70251-6 · Cited by 654
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
Shimabukuro, T. T., Nguyen, M., Martin, D., & DeStefano, F. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.07.035 · Cited by 608
Clinical recognition of meningococcal disease in children and adolescents
Thompson, M. J., Ninis, N., Perera, R., Mayon-White, R., Phillips, C., Bailey, L., Harnden, A., Mant, D., & Levin, M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)67932-4 · Cited by 565
Postsplenectomy sepsis and its mortality rate: Actual versus perceived risks
Holdsworth, R. J., Irving, A. D., & Cuschieri, A. (1991) · Journal of British Surgery · doi:10.1002/bjs.1800780904 · Cited by 481
Risk of Infection and Death Among Post-splenectomy Patients
Bisharat, N., Omari, H., Lavi, I., & Raz, R. (2001) · Journal of Infection · doi:10.1053/jinf.2001.0904 · Cited by 468
Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity
Maiden, M. C. J., Ibarz-Pavón, A. B., Urwin, R., Gray, S. J., Andrews, N. J., Clarke, S. C., Walker, A. M., Evans, M. R., Kroll, J. S., Neal, K. R., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/527401 · Cited by 442
Meningococcal surrogates of protection?serum bactericidal antibody activity
BORROW, R., BALMER, P., & MILLER, E. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.051 · Cited by 413
Update on overall prevalence of major birth defects - Atlanta, Georgia, 1978-2005: (403792008-002)
(2008) · PsycEXTRA Dataset · doi:10.1037/e403792008-002 · Cited by 409
Walker, T. Y., Elam-Evans, L. D., Yankey, D., Markowitz, L. E., Williams, C. L., Mbaeyi, S. A., Fredua, B., & Stokley, S. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6733a1 · Cited by 395
Self-citationElam-Evans, L. D., Yankey, D., Singleton, J. A., Sterrett, N., Markowitz, L. E., Williams, C. L., Fredua, B., McNamara, L., & Stokley, S. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6933a1 · Cited by 366
McNamara, L. A., Topaz, N., Wang, X., Hariri, S., Fox, L., & MacNeil, J. R. (2017) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6627e1 · Cited by 349
Self-citationMeningococcal disease: Clinical presentation and sequelae
Pace, D., & Pollard, A. J. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.12.062 · Cited by 347
(2005) · PsycEXTRA Dataset · doi:10.1037/e548762006-001 · Cited by 311
Read, R. C., Baxter, D., Chadwick, D. R., Faust, S. N., Finn, A., Gordon, S. B., Heath, P. T., Lewis, D. J. M., Pollard, A. J., Turner, D. P. J., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60842-4 · Cited by 280
Borrow, R., Alarcón, P., Carlos, J., Caugant, D. A., Christensen, H., Debbag, R., De Wals, P., Echániz-Aviles, G., Findlow, J., Head, C., et al. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1258308 · Cited by 269
Santolaya, M. E., O'Ryan, M. L., Valenzuela, M. T., Prado, V., Vergara, R., Muñoz, A., Toneatto, D., Graña, G., Wang, H., Clemens, R., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61713-3 · Cited by 260
Daugla, D., Gami, J., Gamougam, K., Naibei, N., Mbainadji, L., Narbé, M., Toralta, J., Kodbesse, B., Ngadoua, C., Coldiron, M., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61612-8 · Cited by 256
The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety
McNeil, M. M., Gee, J., Weintraub, E. S., Belongia, E. A., Lee, G. M., Glanz, J. M., Nordin, J. D., Klein, N. P., Baxter, R., Naleway, A. L., et al. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.07.073 · Cited by 247
Tapia, M. D., Sow, S. O., Tamboura, B., Tégueté, I., Pasetti, M. F., Kodio, M., Onwuchekwa, U., Tennant, S. M., Blackwelder, W. C., Coulibaly, F., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30054-8 · Cited by 245
Trotter, C. L., Lingani, C., Fernandez, K., Cooper, L. V., Bita, A., Tevi-Benissan, C., Ronveaux, O., Préziosi, M.-P., & Stuart, J. M. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30301-8 · Cited by 242
Meningococcal disease and the complement system
Lewis, L. A., & Ram, S. (2014) · Virulence · doi:10.4161/viru.26515 · Cited by 227
MacNeil, J. R., Rubin, L., Folaranmi, T., Ortega-Sanchez, I. R., Patel, M., & Martin, S. W. (2015) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6441a3 · Cited by 226
Self-citationImpact of the Serogroup A Meningococcal Conjugate Vaccine, MenAfriVac, on Carriage and Herd Immunity
Kristiansen, P. A., Diomandé, F., Ba, A. K., Sanou, I., Ouédraogo, A., Ouédraogo, R., Sangaré, L., Kandolo, D., Aké, F., Saga, I. M., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis892 · Cited by 212
Tobacco smoke as a risk factor for meningococcal disease
FISCHER, M., HEDBERG, K., CARDOSI, P., PLIKAYTIS, B. D., HOESLY, F. C., STEINGART, K. R., BELL, T. A., FLEMING, D. W., WENGER, J. D., & PERKINS, B. A. (1997) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199710000-00015 · Cited by 210
Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England
Ladhani, S. N., Andrews, N., Parikh, S. R., Campbell, H., White, J., Edelstein, M., Bai, X., Lucidarme, J., Borrow, R., & Ramsay, M. E. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1901229 · Cited by 210
Influenza A and meningococcal disease
Cartwright, K. A. V., Jones, D. M., Kaczmarski, E., Smith, A. J., Stuart, J. M., & Palmer, S. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)91112-8 · Cited by 205
Folaranmi, T. A., Rubin, L. G., Martin, S. W., Patel, M., & MacNeil, J. R. (2015) · PubMed Central · Cited by 202
Self-citationMeningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia
Marshall, H. S., McMillan, M., Koehler, A. P., Lawrence, A., Sullivan, T. R., MacLennan, J. M., Maiden, M. C. J., Ladhani, S. N., Ramsay, M. E., Trotter, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1900236 · Cited by 189
Risk Factors for Meningococcal Disease in College Students
Bruce, M. G. (2001) · JAMA · doi:10.1001/jama.286.6.688 · Cited by 178
ACOG PRACTICE BULLETIN: NO 24, FEB 2001, MANAGEMENT OF RECURRENT EARLY PREGNANCY LOSS
(2002) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(02)00197-2 · Cited by 174
KEYSERLING, H. L., Papa, T., Koranyi, K., Ryall, R., Bassily, E. L., Bybel, M. J., Sullivan, K., Gilmet, G., & Reinhardt, A. (2005) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.159.10.907 · Cited by 156
Smoking, the environment and meningococcal disease: a case control study
Stanwell, R. E., Stuart, J. M., Hughes, A., Robinson, P. M., Griffin, M., & Cartwright, K. A. V. (1994) · Epidemiology and Infection · doi:10.1017/s0950268800057733 · Cited by 156
Update on Overall Prevalence of Major Birth Defects—Atlanta, Georgia, 1978-2005
(2008) · JAMA · doi:10.1001/jama.299.7.756 · Cited by 154
Neal, K. R. (2000) · BMJ · doi:10.1136/bmj.320.7238.846 · Cited by 148
Complement deficiency states and meningococcal disease
Figueroa, J. E., Andreoni, J., & Densen, P. (1993) · Immunologic Research · doi:10.1007/bf02918259 · Cited by 144
Current Epidemiology and Trends in Meningococcal Disease—United States, 1996–2015
MacNeil, J. R., Blain, A. E., Wang, X., & Cohn, A. C. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix993 · Cited by 140
Self-citationKonar, M., & Granoff, D. M. (2017) · Blood · doi:10.1182/blood-2017-05-781450 · Cited by 138
Richmond, P., Marshall, H. S., Nissen, M. D., Jiang, Q. L., Jansen, K. U., Garcés‐Sánchez, M., Martinón‐Torres, F., Beeslaar, J. F., Szenborn, L., Wysocki, J., et al. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70087-7 · Cited by 131
Cost-Effectiveness of Conjugate Meningococcal Vaccination Strategies in the United States
Shepard, C. W., Ortega‐Sanchez, I. R., Scott, R. D., Rosenstein, N. E., & and the ABCs Team (2005) · PEDIATRICS · doi:10.1542/peds.2004-2514 · Cited by 127
Active Surveillance for Adverse Events: The Experience of the Vaccine Safety Datalink Project
Yih, W. K., Kulldorff, M., FIREMAN, B. H., Shui, I. M., Lewis, E. M., Klein, N. P., Baggs, J. M., Weintraub, E., Belongia, E. A., Naleway, A. L., et al. (2011) · PEDIATRICS · doi:10.1542/peds.2010-1722i · Cited by 127
Immune Response to Meningococcal Serogroup C Conjugate Vaccine in Asplenic Individuals
Balmer, P., Falconer, M., McDonald, P., Andrews, N. J., Fuller, E. P., Riley, C., Kaczmarski, E. B., & Borrow, R. (2003) · Infection and Immunity · doi:10.1128/iai.72.1.332-337.2004 · Cited by 121
Sporadic Meningococcal Disease in Adults: Results of a 5-Year Population-Based Study
Stephens, D. S., Hajjeh, R. A., Baughman, W. S., Harvey, R. C., Wenger, J. D., & Farley, M. M. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-12-199512150-00007 · Cited by 120
Self-citationJackson, L. A., Baxter, R. P., Reisinger, K. S., Karsten, A., Shah, J., Bedell, L., Dull, P. M., & the V59P13 Study Group (2009) · Clinical Infectious Diseases · doi:10.1086/599117 · Cited by 107
McNamara, L. A., Topaz, N., Wang, X., Hariri, S., Fox, L. M., & MacNeil, J. R. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14426 · Cited by 103
Self-citationIndications for the Immunological Evaluation of Patients with Meningitis
Overturf, G. D. (2003) · Clinical Infectious Diseases · doi:10.1086/345527 · Cited by 99
Soeters, H. M., Whaley, M. J., Alexander-Scott, N. E., Kanadanian, K. V., MacNeil, J. R., Martin, S. W., McNamara, L. A., Sicard, K., Vanner, C., Vuong, J. T., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix091 · Cited by 95
Self-citationRiedl, M., Thorner, P. S., & Licht, C. P. B. (2016) · Pediatric Nephrology · doi:10.1007/s00467-015-3310-4 · Cited by 93
Chen, W. H., Neuzil, K. M., Boyce, C., Pasetti, M. F., Reymann, M. K., Martellet, L., Hosken, N. A., LaForce, F. M., Dhere, R. M., Pisal, S. S., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30400-6 · Cited by 89
Muzzi, A., Brozzi, A., Serino, L., Bodini, M., Abad, R., Caugant, D. A., Comanducci, M., de Lemos, A. P. S., Gorla, M. C., Křížová, P., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2018.12.061 · Cited by 89
Elevated Risk for Invasive Meningococcal Disease Among Persons With HIV
Miller, L., Arakaki, L. S., Ramautar, A., Bodach, S. D., Braunstein, S., Kennedy, J., Steiner-Sichel, L., Ngai, S., Shepard, C. W., & Weiss, D. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-160-1-201401070-00731 · Cited by 88
Gill, C. J., Baxter, R. P., Anemona, A., Ciavarro, G., & Dull, P. M. (2010) · Human Vaccines · doi:10.4161/hv.6.11.12849 · Cited by 88
Reisinger, K. S., Baxter, R. P., Block, S. L., Shah, J., Bedell, L., & Dull, P. M. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00207-09 · Cited by 86
MacNeil, J. R., Rubin, L. G., Patton, M. E., Ortega‐Sanchez, I. R., & Martin, S. W. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6543a3 · Cited by 86
Self-citationArguedas, A. G., Soley, C., Loaiza, C., Rincon, G., Guevara, S., Perez, A., Porras, W., Alvarado, O., Aguilar, L., Abdelnour, A., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.02.045 · Cited by 85
Effectiveness and Duration of Protection of One Dose of a Meningococcal Conjugate Vaccine
Cohn, A. C., MacNeil, J. R., Harrison, L. H., Lynfield, R., Reingold, A. L., Schaffner, W., Zell, E. R., Plikaytis, B. D., Wang, X., Messonnier, N. E., et al. (2017) · PEDIATRICS · doi:10.1542/peds.2016-2193 · Cited by 83
Self-citationMarshall, H. S., Richmond, P., Nissen, M. D., et al. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.01.021 · Cited by 82
Santolaya, M. E., O’Ryan, M., Valenzuela, M. T., et al. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.25505 · Cited by 82
Cohen, C., Singh, E., Wu, H. M., Martin, S. W., de Gouveia, L., Klugman, K. P., Meiring, S. T., Govender, N. P., & von Gottberg, A. (2010) · AIDS · doi:10.1097/qad.0b013e32833a2520 · Cited by 78
Jackson, L. A., Jacobson, R. M., Reisinger, K. S., Anemona, A., Danzig, L. E., & Dull, P. M. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31818a0237 · Cited by 76
Folaranmi, T. A., Kretz, C. B., Kamiya, H., MacNeil, J. R., Whaley, M. J., Blain, A., Antwi, M., Dorsinville, M., Pacilli, M., Smith, S., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix438 · Cited by 75
Self-citationPlatonov, A. E. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00440-7 · Cited by 73
Immunogenicity of a Meningococcal B Vaccine during a University Outbreak
Basta, N. E., Mahmoud, A. A. F., Wolfson, J. A., Ploß, A., Heller, B. L., Hanna, S., Johnsen, P., Izzo, R., Grenfell, B. T., Findlow, J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1514866 · Cited by 73
McNamara, L. A., Thomas, J. D., MacNeil, J., Chang, H. Y., Day, M., Fisher, E., Martin, S., Poissant, T., Schmink, S. E., Steward-Clark, E., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix446 · Cited by 72
Self-citationBrehony, C., Rodrigues, C. M. C., Borrow, R., Smith, A. H., Cunney, R., Moxon, E. R., & Maiden, M. C. J. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.08.015 · Cited by 71
McNeil, L. K., Donald, R. G. K., Gribenko, A. V., French, R., Lambert, N. D., Harris, S. L., Jones, T. R., Li, S., Zlotnick, G. W., Vogel, U. F., et al. (2018) · mBio · doi:10.1128/mbio.00036-18 · Cited by 70
Baxter, R. P., Baine, Y., Ensor, K., Bianco, V., Friedland, L. R., & Miller, J. M. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3182054ab9 · Cited by 69
Andreoni, J., Käyhty, H. M., & Densen, P. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.1.227 · Cited by 68
Halperin, S. A., Gupta, A. K., Jeanfreau, R. J., Klein, N. P., Reisinger, K. S., Walter, E. B., Bedell, L., Gill, C. J., & Dull, P. M. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.09.092 · Cited by 64
Coadministration of a 9-Valent Human Papillomavirus Vaccine With Meningococcal and Tdap Vaccines
Schilling, A., Parra, M. M., Gutierrez, M., Restrepo, J., Ucrós, S., Herrera, T., Engel, E., Huicho, L., Shew, M. L., Maansson, R., et al. (2015) · PEDIATRICS · doi:10.1542/peds.2014-4199 · Cited by 64
Klein, N. P., Reisinger, K. S., Johnston, W., Odrljin, T., Gill, C. J., Bedell, L., & Dull, P. M. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31823dce5c · Cited by 63
Flacco, M. E., Manzoli, L., Rosso, A., Marzuillo, C., Bergamini, M., Stefanati, A., Cultrera, R., Villari, P., Ricciardi, W., Ioannidis, J. P. A., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30048-3 · Cited by 62
Deceuninck, G., Lefebvre, B., Tsang, R. S. W., Betala-Belinga, J.-F., Serres, G. D., & Wals, P. D. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.06.021 · Cited by 62
Safety, Tolerability, and Immunogenicity of Gardasil Given Concomitantly With Menactra and Adacel
Reisinger, K. S., Block, S. L., Collins-Ogle, M. D., Marchant, C. D., Catlett, M., Radley, D. R., Sings, H. L., Haupt, R. M., Garner, E. I. O., & for the Protocol 025 Investigators (2010) · PEDIATRICS · doi:10.1542/peds.2009-2336 · Cited by 60
Lee, G. M., Carr, W., ACIP Evidence-Based Recommendations Work Group, ACIP Evidence Based Recommendations Work Group, Reingold, A. L., Hunter, P. R., Lee, G. M., Temte, J., Campos-Outcalt, D. E., Rubin, L. G., et al. (2018) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6745a4 · Cited by 60
Self-citationBrundage, J. F., Ryan, M. A. K., Feighner, B. H., & Erdtmann, F. J. (2002) · Clinical Infectious Diseases · doi:10.1086/344273 · Cited by 59
Pina, L. M., Bassily, E. L., Machmer, A., Hou, V., & Reinhardt, A. (2012) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318268dfe4 · Cited by 58
Vesikari, T., Østergaard, L. J., Díez‐Domingo, J., et al. (2015) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piv039 · Cited by 58
Block, S. L., Szenborn, L., Daly, W., Jackowska, T., D’Agostino, D., Han, L., Dull, P. M., & Smolenov, I. V. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.03.001 · Cited by 57
BLACK, S. B., Klein, N. P., Shah, J., Bedell, L., Karsten, A., & Dull, P. M. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.104 · Cited by 54
Stamboulián, D., Lopardo, G. D., López, P., Cortes-Barbosa, C., Valencia, A., Bedell, L., Karsten, A., & Dull, P. M. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2010.03.017 · Cited by 54
Siberry, G. K., Williams, P. L., Luján‐Zilbermann, J., et al. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181c38f3b · Cited by 54
Nolan, T. M., Santolaya, M. E., de Looze, F. J., Marshall, H. S., Richmond, P., Henein, S., Rheault, P., Heaton, K., Perrett, K. P., Garfield, H., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2018.12.059 · Cited by 52
Perrett, K. P., McVernon, J., Richmond, P., Marshall, H. S., Nissen, M. D., August, A., Percell, S., Toneatto, D., & Nolan, T. M. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.06.103 · Cited by 51
Gasparini, R., Conversano, M., Bona, G., Gabutti, G., Anemona, A., Dull, P. M., & Ceddia, F. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00436-09 · Cited by 50
Simmons, R., Kirwan, P., Beebeejaun, K., Riordan, A., Borrow, R., Ramsay, M. E., Delpech, V., Lattimore, S., & Ladhani, S. N. (2015) · BMC Medicine · doi:10.1186/s12916-015-0538-6 · Cited by 50
Rubin, L. G., Cohn, A. C., MacNeil, J. R., & Messonnier, N. E. (2013) · PubMed Central · Cited by 50
Self-citationMeningococcal Disease Among College-Aged Young Adults: 2014–2016
Mbaeyi, S. A., Joseph, S. J., Blain, A. E., Wang, X., Hariri, S., & MacNeil, J. R. (2018) · PEDIATRICS · doi:10.1542/peds.2018-2130 · Cited by 48
Self-citationMbaeyi, S. A., Pondo, T., Blain, A. E., Yankey, D., Cubeñas-Potts, C., Cohn, A. C., Hariri, S., Shang, N., & MacNeil, J. R. (2020) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2020.1990 · Cited by 48
Self-citationZheteyeva, Y. A., Moro, P. L., Yue, X., & Broder, K. R. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.02.027 · Cited by 47
Jacobson, R. M., Jackson, L. A., Reisinger, K. S., Izu, A., Odrljin, T. M., & Dull, P. M. (2012) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318279ac38 · Cited by 47
Read, R. C., Dull, P. M., Bai, X., Nolan, K., Findlow, J., Bazaz, R., Kleinschmidt, A., McCarthy, M. C., Wang, H., Toneatto, D., et al. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.11.071 · Cited by 47
Alarcon, W. A., Epidemiology, S. A. B. L., & (ABLES), S. (2015) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6254a4 · Cited by 46
Rajam, G., Stella, M., Kim, E., Paulos, S., Boccadifuoco, G., Serino, L., Carlone, G. M., & Medini, D. (2017) · mSphere · doi:10.1128/msphere.00261-17 · Cited by 46
Baxter, R. P., Reisinger, K. S., Block, S. L., Izu, A., Odrljin, T. M., & Dull, P. M. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.02.025 · Cited by 45
Chang, L.-J., HEDRICK, J. A., Christensen, S., Pan, J., Jordanov, E., & Dhingra, M. S. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.03.017 · Cited by 45
MacNeil, J. R., Rubin, L. G., McNamara, L. A., et al. (2014) · PubMed · Cited by 44
Self-citationBaxter, R. P., Baine, Y., Kolhe, D. A., Baccarini, C. I., Miller, J. M., & der Wielen, M. V. (2015) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000866 · Cited by 43
Muse, D. D., Christensen, S., Bhuyan, P. K., Absalon, J., Eiden, J., Jones, T. R., York, L. J., Jansen, K. U., O’Neill, R. E., Harris, S. L., et al. (2016) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001124 · Cited by 42
Senders, S. D., Bhuyan, P. K., Jiang, Q. L., Absalon, J., Eiden, J., Jones, T. R., York, L. J., Jansen, K. U., O’Neill, R. E., Harris, S. L., et al. (2016) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001072 · Cited by 42
Harris, S. L., Donald, R. G. K., Hawkins, J. C., Tan, C., O’Neill, R. E., McNeil, L. K., Perez, J. L., Anderson, A. S., Jansen, K. U., & Jones, T. R. (2016) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001399 · Cited by 42
Vesikari, T., Wysocki, J., Beeslaar, J. F., Eiden, J., Jiang, Q. L., Jansen, K. U., Jones, T. R., Harris, S. L., O’Neill, R. E., York, L. J., et al. (2016) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piv064 · Cited by 41
Baxter, R. P., Keshavan, P., Welsch, J. A., Han, L., & Smolenov, I. V. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1136040 · Cited by 41
Jackson, L. A., Yu, O., Nelson, J. C., Belongia, E. A., Hambidge, S. J., Baxter, R. P., Naleway, A. L., Nordin, J. D., Baggs, J. M., & Iskander, J. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.06.038 · Cited by 38
Epidemiology of Meningococcal Disease Outbreaks in the United States, 2009–2013
Mbaeyi, S. A., Blain, A. E., Whaley, M. J., Wang, X., Cohn, A. C., & MacNeil, J. R. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy548 · Cited by 38
Self-citationEsteves-Jaramillo, A., Koehler, T., Jeanfreau, R. J., Neveu, D., Jordanov, E., & Dhingra, M. S. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.04.067 · Cited by 38
Siberry, G. K., Warshaw, M. G., Williams, P. L., et al. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318236c67b · Cited by 35
Wheeler, C. M., Harvey, B. M., Pichichero, M. E., Simon, M. W., Combs, S. P., Blatter, M. M., Marshall, G. S., Catteau, G., Dobbelaere, K., Descamps, D., et al. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31822d28df · Cited by 34
Baxter, R. P., Reisinger, K. S., Block, S. L., Percell, S., Odrljin, T. M., Dull, P. M., & Smolenov, I. V. (2014) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000438 · Cited by 32
Kirstein, J. L., Pina, M., Pan, J., Jordanov, E., & Dhingra, M. S. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1733868 · Cited by 32
Granoff, D. M., Costa, I., Konar, M., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv081 · Cited by 31
Nolan, T. M., Nissen, M. D., Naz, A., Shepard, J. S., Bedell, L., Hohenboken, M. J., Odrljin, T. M., & Dull, P. M. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.27051 · Cited by 30
Weston, W. M., Friedland, L. R., Wu, X., & Howe, B. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.11.057 · Cited by 29
Taha, M., Hawkins, J. C., Liberator, P., Deghmane, A., Andrew, L., Li, H., Jones, T. R., McNeil, L. K., O’Neill, R. E., Perez, J. L., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.01.066 · Cited by 29
Fiorito, T. M., Baird, G. L., Alexander-Scott, N. E., Bornschein, S., Kelleher, C., Du, N. R., & Dennehy, P. H. (2017) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001742 · Cited by 29
Frota, A. C. C., Milagres, L. G., Harrison, L. H., Ferreira, B., Barreto, D. M., Pereira, G. S., Cruz, A. C., PEREIRA-MANFRO, W. F., de Oliveira, R. H., de Abreu, T. F., et al. (2014) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000630 · Cited by 27
Safety of Quadrivalent Meningococcal Conjugate Vaccine in 11- to 21-Year-Olds
Tseng, H. F., Sy, L. S., Ackerson, B. K., Hechter, R. C., Tartof, S. Y., Haag, M. D. M., Slezak, J. M., Luo, Y., Fischetti, C. A., Takhar, H. S., et al. (2016) · PEDIATRICS · doi:10.1542/peds.2016-2084 · Cited by 27
Oldfield, N. J., Green, L. R., Parkhill, J., Bayliss, C. D., & Turner, D. P. J. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix596 · Cited by 27
Serres, G. D., Billard, M., Gariépy, M.-C., Rouleau, I., Toth, E., Landry, M., Boulianne, N., Gagné, H., Gîlca, V., Deceuninck, G., et al. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.10.095 · Cited by 25
Lee, H. J., Chung, M., Kim, W. J., Hong, Y. J., Choi, K. M., Lee, J., Oh, C. E., Welsch, J. A., Kim, K., Hong, K. B., et al. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2014.06.008 · Cited by 24
Gasparini, R., Tregnaghi, M., Keshavan, P., Ypma, E., Han, L., & Smolenov, I. V. (2015) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000930 · Cited by 24
Lujan, E., Partridge, E., Giuntini, S., Ram, S., & Granoff, D. M. (2017) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00121-17 · Cited by 24
Lujan, E., Winter, K., Rovaris, J., Liu, Q., & Granoff, D. M. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix519 · Cited by 24
Szenborn, L., Block, S. L., Jackowska, T., Konior, R., D’Agostino, D., Smolenov, I. V., Toneatto, D., & Welsch, J. A. (2018) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001896 · Cited by 23
Pichichero, M. E., Papa, T., Blatter, M. M., Mitchell, D., Kratz, R., Sneed, J., Bassily, E. L., Casey, J. R., & Gilmet, G. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000243215.46312.4a · Cited by 22
Abdelnour, A., Silas, P. E., Lamas, M. R. V., Aragón, C. F. G., Chiu, N., Chiu, C., Acuña, T. H., Castrejón, T. D. L., Izu, A., Odrljin, T. M., et al. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.12.034 · Cited by 22
Safety of a meningococcal group B vaccine used in response to two university outbreaks
Duffy, J., Johnsen, P., Ferris, M., Miller, M. K., Leighton, K., McGilvray, M., McNamara, L. A., Breakwell, L., Yon, Y., Bhavsar, T. R., et al. (2017) · Journal of American College Health · doi:10.1080/07448481.2017.1312418 · Cited by 22
Self-citationKorzeniewski, K., Skoczyńska, A., Guzek, A., Konior, M., Chciałowski, A., Waśko, I., Markowska, M., & Zwolińska, E. (2014) · Advances in experimental medicine and biology · doi:10.1007/5584_2014_22 · Cited by 21
Alberer, M., Burchard, G. D., Jelínek, T., Reisinger, E. C., Beran, J., Hlavata, L. C., Forleo‐Neto, E., Dagnew, A. F., & Arora, A. K. (2014) · Journal of Travel Medicine · doi:10.1111/jtm.12164 · Cited by 19
Impaired antibody response to conjugated meningococcal serogroup C vaccine in asplenic patients
Meerveld-Eggink, A., de Weerdt, O., de Voer, R. M., Berbers, G. A. M., van Velzen‐Blad, H., Vlaminckx, B. J. M., Biesma, D. H., & Rijkers, G. T. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-1129-2 · Cited by 18
Robertson, C. A., Greenberg, D. P., HEDRICK, J. A., Pichichero, M. E., Decker, M. D., & Saunders, M. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.09.003 · Cited by 18
Spoulou, V. I., Tzanakaki, G., Lekka, S., Chouliaras, G. L., Ladis, V., & Theodoridou, M. N. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.03.080 · Cited by 17
Block, S. L., Shepard, J. S., Garfield, H., Xie, F., Han, L., Dull, P. M., & Smolenov, I. V. (2015) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000965 · Cited by 16
Cho, B., Clark, T. A., Messonnier, N. E., Ortega‐Sanchez, I. R., Weintraub, E., & Messonnier, M. L. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.050 · Cited by 16
Hansen, J. R., Zhang, L., Klein, N. P., Robertson, C. A., Decker, M. D., Greenberg, D. P., Bassily, E. L., & Baxter, R. P. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.09.032 · Cited by 16
Introduction of a second MenB vaccine into Europe – needs and opportunities for public health
Findlow, J., Nuttens, C., & Kriz, P. (2019) · Expert Review of Vaccines · doi:10.1080/14760584.2019.1578217 · Cited by 15
Alberer, M., Burchard, G. D., Jelı́nek, T., Reisinger, E. C., Meyer, S., Forleo‐Neto, E., Dagnew, A. F., & Arora, A. K. (2014) · Journal of Travel Medicine · doi:10.1111/jtm.12180 · Cited by 13
Ilyina, N. I., Михайловна, Х. С., Namazova-Baranova, L. S., Asatryan, A., Benashvili, M., Tkhostova, E., Bhusal, C., & Arora, A. K. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.29571 · Cited by 13
Sharkey, K., Beernink, P. T., Langley, J. M., Gantt, S. M., Quach, C., Dold, C., Liu, Q., Galvan, M. D., & Granoff, D. M. (2019) · mSphere · doi:10.1128/msphere.00393-19 · Cited by 12
Johnston, W. (2014) · Journal of Vaccines & Vaccination · doi:10.4172/2157-7560.1000231 · Cited by 10
Souza, A. R., Maruyama, C., Sáfadi, M. A. P., Lopes, M. H., Azevedo, R. S., Findlow, H., Bai, X., Borrow, R., & Weckx, L. Y. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.06.072 · Cited by 10
Oliver, S. E., & Mbaeyi, S. A. (2018) · Current Epidemiology Reports · doi:10.1007/s40471-018-0170-z · Cited by 9
Self-citationTipton, M. E., Daly, W., Senders, S. D., Block, S. L., Lattanzi, M., Mzolo, T., Barbi, S., Pellegrini, M., & Keshavan, P. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.08.065 · Cited by 9
Frota, A. C. C., Harrison, L. H., Ferreira, B., Barreto, D. M., de Castro, R. B. N., da Silva, G. P., de Oliveira, R. H., de Abreu, T. F., Milagres, L. G., & Hofer, C. B. (2017) · Jornal de Pediatria · doi:10.1016/j.jped.2017.01.003 · Cited by 3
Lee, H. J., Jo, D. S., Kim, Y. K., Lee, H., Kim, K., Lee, D.-K., Curina, C., Costantini, M., Barbi, S., Miao, Y., et al. (2019) · Clinical and Experimental Vaccine Research · doi:10.7774/cevr.2019.8.2.94 · Cited by 2
Cited by
Kucharzik, T., Ellul, P., Greuter, T., Rahier, J. F., Verstockt, B., Abreu, C., Albuquerque, A., Allocca, M., Esteve, M., Farraye, F. A., et al. (2021) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjab052 · Cited by 480
Kümpfel, T., Giglhuber, K., Aktas, O., Ayzenberg, I., Bellmann-Strobl, J., Häußler, V., Havla, J., Hellwig, K., Hümmert, M. W., Jarius, S., et al. (2024) · Journal of Neurology · doi:10.1007/s00415-023-11910-z · Cited by 258
Metadata
- Authors
- Mbaeyi, S. A., Bozio, C. H., Duffy, J., Rubin, L. G., Hariri, S., Stephens, D. S., & MacNeil, J. R.
- Venue
- MMWR. Recommendations and Reports
- Published
- 2020-09-25
- Volume
- 69
- Issue
- 9
- Pages
- 1-41
- ISSN
- 1057-5987 (ISSN-L)
- 1545-8601
- OpenAlex
- W3088822708
- Cited by
- 321
- References
- 154
- FWCI
- 21.39
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.